OS Therapies Incorporated (OSTX) Dividend History

OS Therapies Incorporated (OSTX) is a biotechnology company focused on developing innovative gene therapies for rare and serious genetic disorders. The company leverages advanced genetic engineering technologies to create treatments aimed at addressing unmet medical needs.

Dividend History

OS Therapies Incorporated currently does not pay dividends

Company News

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.

Benzinga

Featured Companies: GOVX ONCY SLS

Page data last updated 07/23/2025 16:57:20 UTC